Foley Equipped

Insights

Stage
All stages
Stage
Foley Represents Samsung Ventures as Investor in $58M Funding Round for WitnessAI_696a5736ed267.jpeg

Louis Lehot and Patrick Daugherty Give Guidance on Crypto-Asset Strategy

Foley & Lardner LLP partners Louis Lehot and Patrick Daugherty provided insights on crypto-asset strategy in the Corporate Counsel article, ...
Read more
Foley Advises Kaia Health on $285M Sale to Sword Health_697ccc03042e4.jpeg

Foley Advises Kaia Health on $285M Sale to Sword Health

Foley & Lardner LLP advised Kaia Health, a digital therapeutics company focused on musculoskeletal (MSK) and pulmonary care, on its ...

Read more
Foley Advises Rivet Health in Acquisition by Zelis_696a5720af508.jpeg

Stablecoins vs. Bitcoin in 2026: Regulation, Realignment and the New Digital Asset Market Structure

When we closed out 2025, the digital asset ecosystem looked nothing like the one we had entered just 12 months ...
Read more
Foley Guides Wasabi Technologies in $70M Equity Funding Round_696905b7b366a.jpeg

Louis Lehot Publishes on Global Digital Asset Ecosystem

Lehot details three digital asset regulation developments that defined 2025, namely regulated stablecoins entering the financial mainstream, the establishment of ...
Read more
Foley Advises SkyWater Technology in Agreement to be Acquired by IonQ_6978d7909f2c0.jpeg

Foley Advises SkyWater Technology in Agreement to be Acquired by IonQ

Foley & Lardner LLP served as legal advisor to SkyWater Technology (NASDAQ: SKYT), the largest exclusively U.S.-based, pure-play semiconductor foundry, ...

Read more
Foley Represents Blockstream in Acquisition of Elysium Lab and European Expansion_6978d7a9831ed.jpeg

Foley Represents Blockstream in Acquisition of Elysium Lab and European Expansion

Foley & Lardner LLP represented Blockstream, the global leader in Bitcoin-powered financial infrastructure, in the acquisition of Lugano-based digital asset ...

Read more
Foley Counsels United Theranostics in Financing with Courage Capital_6978d7b76d420.jpeg

Foley Counsels United Theranostics in Financing with Courage Capital

Foley & Lardner LLP served as legal counsel to United Theranostics, a leading provider of radiopharmaceutical therapy and supportive molecular ...

Read more
Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL_6974e38324483.jpeg

Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL

Foley & Lardner LLP represented TCGX Crossover (TCGX) as an investor in the $287 million Series D1 financing for CORXEL, ...

Read more
Foley Represents DLB in Sale of Majority Stake to Accenture_6974e39407356.jpeg

Foley Represents DLB in Sale of Majority Stake to Accenture

Foley & Lardner LLP represented DLB Associates and its affiliated companies (collectively “DLB”), an industry leader and trailblazer in engineering ...

Read more
Subscribe to our newsletter
Subscribe

© 2025 Foley & Lardner LLP
Attorney Advertisement
Images of people may not be Foley personnel.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome.